IBER.WS
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
IBER.WS
Delisted
IBER.WS was delisted on the 15th of February, 2023.
21 hedge funds and large institutions have $3.14M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
21
Holding in Top 10
–
Calls
$2.24M
Puts
–
Top Buyers
1 | +$73K | |
2 | +$65.6K | |
3 | +$33K | |
4 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
+$32K |
5 |
Wells Fargo
San Francisco,
California
|
+$23K |